Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-02

Clinical Trial Update: The Efficacy of Botulinum Toxin vs. Corticosteroid for the Treatment of Refractory Plantar Fasciitis [Phase 2, Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 2/3 clinical trial comparing botulinum toxin to corticosteroid for the treatment of refractory plantar fasciitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)
  • Corticosteroid (corticosteroid)

Snippet

Sponsor: Western Institute for Veterans Research | Conditions: Plantar Fasciitis | Phase 2, Phase 3 | Status: COMPLETED